CY1119240T1 - Εξωθηση τηγματος πολλαπλων σφαιρικων σωματιδιων - Google Patents

Εξωθηση τηγματος πολλαπλων σφαιρικων σωματιδιων

Info

Publication number
CY1119240T1
CY1119240T1 CY20171100796T CY171100796T CY1119240T1 CY 1119240 T1 CY1119240 T1 CY 1119240T1 CY 20171100796 T CY20171100796 T CY 20171100796T CY 171100796 T CY171100796 T CY 171100796T CY 1119240 T1 CY1119240 T1 CY 1119240T1
Authority
CY
Cyprus
Prior art keywords
extraction
sphere particles
nozzles
filament
multiple sphere
Prior art date
Application number
CY20171100796T
Other languages
English (en)
Inventor
Geoffrey Gerard Hayes
Vincenzo Martinelli
Hassan Mohammad
Harjit Tamber
Malcolm Walden
Steve Whitelock
Derek Allan Prater
Original Assignee
Euro-Celtique S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32011772&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1119240(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Euro-Celtique S.A. filed Critical Euro-Celtique S.A.
Publication of CY1119240T1 publication Critical patent/CY1119240T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η εφεύρεση αφορά σε μία μέθοδο για παρασκευή φαρμακευτικού εξωθήματος ελεγχόμενης απελευθέρωσης χρησιμοποιώντας εξωθητή τήγματος, όπου ο εξωθητής τήγματος περιλαμβάνει κεφαλή φιλιέρας που υποστηρίζει πλάκα φιλιέρας στην οποία είναι τοποθετημένα στόμια και έναν κόφτη γειτονικό προς την κεφαλή φιλιέρας και όπου ο κόφτης κόβει το εξωθούμενο μείγμα καθώς αυτό αναφύεται υπό πίεση και εισέτι τετηγμένο ή μαλακυνθέν από τα στόμια της πλάκας φιλιέρας.
CY20171100796T 2004-02-12 2017-07-25 Εξωθηση τηγματος πολλαπλων σφαιρικων σωματιδιων CY1119240T1 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0403098.7A GB0403098D0 (en) 2004-02-12 2004-02-12 Extrusion

Publications (1)

Publication Number Publication Date
CY1119240T1 true CY1119240T1 (el) 2018-02-14

Family

ID=32011772

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20171100796T CY1119240T1 (el) 2004-02-12 2017-07-25 Εξωθηση τηγματος πολλαπλων σφαιρικων σωματιδιων

Country Status (11)

Country Link
US (2) US20050191352A1 (el)
EP (1) EP1586311B1 (el)
CY (1) CY1119240T1 (el)
DK (1) DK1586311T3 (el)
ES (1) ES2628960T3 (el)
GB (1) GB0403098D0 (el)
HU (1) HUE035445T2 (el)
LT (1) LT1586311T (el)
PL (1) PL1586311T3 (el)
PT (1) PT1586311T (el)
SI (1) SI1586311T1 (el)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
TWI350762B (en) * 2004-02-12 2011-10-21 Euro Celtique Sa Particulates
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US7807715B2 (en) * 2006-06-09 2010-10-05 Ucb Pharma Gmbh Pharmaceutical compositions comprising fesoterodine
WO2008100865A1 (en) 2007-02-13 2008-08-21 Nye Paul H A personal affector machine
DE102007009242A1 (de) * 2007-02-22 2008-09-18 Evonik Röhm Gmbh Pellets mit magensaftresistenter Wirkstoff-Matix
DE102007009243A1 (de) 2007-02-22 2008-09-18 Evonik Röhm Gmbh Pellets mit einer Wirkstoff-Matrix und einem Polymerüberzug, sowie ein Verfahren zur Herstellung der Pellets
CA2711473C (en) * 2008-01-10 2016-01-26 Evonik Roehm Gmbh Coated pharmaceutical or nutraceutical preparation with enhanced active substance release in the colon
WO2009086942A1 (en) * 2008-01-10 2009-07-16 Evonik Röhm Gmbh Coated pharmaceutical or nutraceutical preparation with accelerated controlled active substance release
BRPI0906467C1 (pt) 2008-01-25 2021-05-25 Gruenenthal Gmbh forma de dosagem farmacêutica com formato exterior modificado resistente à ruptura e com liberação controlada
WO2009134848A1 (en) * 2008-04-30 2009-11-05 Novartis Ag Continuous process for making pharmaceutical compositions
GB0909680D0 (en) 2009-06-05 2009-07-22 Euro Celtique Sa Dosage form
PE20121067A1 (es) 2009-07-22 2012-09-05 Gruenenthal Chemie Forma de dosificacion de liberacion controlada extruida por fusion en caliente
WO2011009604A1 (en) 2009-07-22 2011-01-27 Grünenthal GmbH Oxidation-stabilized tamper-resistant dosage form
US9232670B2 (en) * 2010-02-02 2016-01-05 Apple Inc. Protection and assembly of outer glass surfaces of an electronic device housing
WO2012028319A1 (en) 2010-09-02 2012-03-08 Grünenthal GmbH Tamper resistant dosage form comprising inorganic salt
GB201020895D0 (en) * 2010-12-09 2011-01-26 Euro Celtique Sa Dosage form
KR20140053158A (ko) 2011-07-29 2014-05-07 그뤼넨탈 게엠베하 즉시 약물 방출을 제공하는 탬퍼-저항성 정제
AR087360A1 (es) 2011-07-29 2014-03-19 Gruenenthal Gmbh Tableta a prueba de manipulacion que proporciona liberacion de farmaco inmediato
JP6282261B2 (ja) * 2012-04-18 2018-02-21 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 不正使用防止および過量放出防止医薬剤形
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
EP3003279A1 (en) 2013-05-29 2016-04-13 Grünenthal GmbH Tamper-resistant dosage form containing one or more particles
AU2014289187B2 (en) 2013-07-12 2019-07-11 Grunenthal Gmbh Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
MX371372B (es) 2013-11-26 2020-01-28 Gruenenthal Gmbh Preparacion de una composicion farmaceutica en polvo por medio de criomolienda.
CA2947786A1 (en) 2014-05-12 2015-11-19 Grunenthal Gmbh Tamper resistant immediate release capsule formulation comprising tapentadol
WO2015181059A1 (en) 2014-05-26 2015-12-03 Grünenthal GmbH Multiparticles safeguarded against ethanolic dose-dumping
JP2018517676A (ja) 2015-04-24 2018-07-05 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 即時放出および溶媒抽出に対する耐性を有する改変防止製剤
WO2017042325A1 (en) 2015-09-10 2017-03-16 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4080134A (en) * 1975-09-23 1978-03-21 Mobil Oil Corporation Apparatus for pelletizing plastic material
GB1603640A (en) * 1977-07-20 1981-11-25 Gist Brocades Nv Enzyme particles
US4331623A (en) * 1978-09-22 1982-05-25 El Paso Polyolefins Company Polymer flow through die
US4327050A (en) * 1980-09-22 1982-04-27 Phillips Petroleum Company Extrusion and pelleting apparatus and method
JPS5996187A (ja) * 1982-11-24 1984-06-02 Nippon Steel Corp ピツチペレツトの製造方法
DE3612212A1 (de) * 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
US4800087A (en) 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
US4948615A (en) * 1988-03-11 1990-08-14 National Starch And Chemical Investment Holding Corporation Extruded gelled products
JPH07112697B2 (ja) * 1989-08-18 1995-12-06 三菱レイヨン株式会社 熱可塑性樹脂球状粒子の製造法
US5085815A (en) * 1989-12-26 1992-02-04 Exxon Chemical Patents Inc. Process of recovering and conveying shaped polymer extrudate
FR2663818B1 (fr) * 1990-06-29 1993-07-09 Rhone Poulenc Nutrition Animale Procede de preparation de granules de principes actifs par extrusion.
ZA919510B (en) 1990-12-05 1992-10-28 Smithkline Beecham Corp Pharmaceutical compositions
DE4138513A1 (de) * 1991-11-23 1993-05-27 Basf Ag Feste pharmazeutische retardform
US5266331A (en) 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
EP0665010B1 (en) * 1992-10-16 2002-09-11 Nippon Shinyaku Company, Limited Method of manufacturing wax matrices
DE4413350A1 (de) * 1994-04-18 1995-10-19 Basf Ag Retard-Matrixpellets und Verfahren zu ihrer Herstellung
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE19504119C2 (de) * 1995-02-08 2000-07-13 S Rockstedt Gmbh Maschf Am Ausgang eines Extruders angebrachter Düsenkopf
DE19509806A1 (de) * 1995-03-21 1996-09-26 Basf Ag Lagerstabile Arzneiformen
DE19509805A1 (de) * 1995-03-21 1996-09-26 Basf Ag Transparente, schnell freisetzende Zubereitungen von nichtsteroidalen Analgetica
CN1165291C (zh) * 1996-05-20 2004-09-08 詹森药业有限公司 具有改进的生物利用度的抗真菌组合物
PL191399B1 (pl) * 1996-10-28 2006-05-31 Gen Mills Inc Sposób kapsułkowania lub osadzania składnika w osnowie w procesie ciągłym, sposób kapsułkowania i/lub osadzania składników w osnowie opartej na węglowodanach, sposób kapsułkowania i/lub osadzania składników w osnowie oraz kapsułka
US6013272A (en) * 1996-12-19 2000-01-11 Valent U.S.A. Corporation Chemically stable, insecticidally active phosphoroamidothioate pellet compositions and methods for their manufacture
US6303607B1 (en) 1998-09-10 2001-10-16 Cv Therapeutics, Inc. Method for administering a sustained release ranolanolazine formulation
ATE279186T1 (de) * 1999-08-31 2004-10-15 Gruenenthal Gmbh Retardierte darreichungsform enthaltend tramadolsaccharinat
US6716449B2 (en) * 2000-02-08 2004-04-06 Euro-Celtique S.A. Controlled-release compositions containing opioid agonist and antagonist
DE10015479A1 (de) * 2000-03-29 2001-10-11 Basf Ag Feste orale Darreichungsformen mit retardierter Wirkstofffreisetzung und hoher mechanischer Stabilität
SE0100200D0 (sv) 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
US20110104214A1 (en) * 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
UA81224C2 (uk) * 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
WO2003004009A1 (en) 2001-07-02 2003-01-16 Geneva Pharmaceuticals, Inc. Pharmaceutical composition
US20030044458A1 (en) * 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
US20030157168A1 (en) 2001-08-06 2003-08-21 Christopher Breder Sequestered antagonist formulations
US7691430B2 (en) * 2001-11-07 2010-04-06 Medwell Foods, Inc. Food material technology with controllable functional characteristics and industrial process applications, and the resulting fabricated foods
DK2425824T5 (en) 2002-04-05 2018-02-12 Mundipharma As Pharmaceutical preparation containing oxycodone and naloxone
US20060165790A1 (en) * 2003-06-27 2006-07-27 Malcolm Walden Multiparticulates
TWI357815B (en) 2003-06-27 2012-02-11 Euro Celtique Sa Multiparticulates
TWI350762B (en) * 2004-02-12 2011-10-21 Euro Celtique Sa Particulates
KR20090029856A (ko) * 2005-01-28 2009-03-23 유로-셀띠끄 소시에떼 아노님 알코올 저항성 제형

Also Published As

Publication number Publication date
HUE035445T2 (en) 2018-05-28
US20090029170A1 (en) 2009-01-29
ES2628960T3 (es) 2017-08-04
EP1586311A2 (en) 2005-10-19
DK1586311T3 (en) 2017-08-14
EP1586311A3 (en) 2011-04-06
SI1586311T1 (sl) 2017-09-29
PL1586311T3 (pl) 2017-10-31
GB0403098D0 (en) 2004-03-17
US9603802B2 (en) 2017-03-28
PT1586311T (pt) 2017-07-13
US20050191352A1 (en) 2005-09-01
LT1586311T (lt) 2017-08-25
EP1586311B1 (en) 2017-05-03

Similar Documents

Publication Publication Date Title
CY1119240T1 (el) Εξωθηση τηγματος πολλαπλων σφαιρικων σωματιδιων
CO6341594A2 (es) Método y ensamble para productos tridimensionales
EP2210970A4 (en) PRESSING MATRIX, MANUFACTURING METHOD THEREFOR, MOLDING MANUFACTURING METHOD, AND ALUMINUM BASE MATRIX FOR PRESSING MATRIX
AR051653A1 (es) Formulaciones
CL2011000371A1 (es) Aparato para la seleccion de semillas para produccion en cantidades comerciales o para investigacion, que comprende una herramienta de extraccion de estructura o tejido de semilla, un porta-semillas que tiene una posicion de extraccion, un posicionador motorizado y un controlador adaptados para mover la herramienta o el porta-semillas.
EP2168746A4 (en) MOLDING METHOD, LENS PRODUCTION METHOD, MOLDING APPARATUS, METHOD FOR PRODUCTION OF PUNCHING MACHINE, APPARATUS FOR MANUFACTURING JIG, PRODUCTION SYSTEM FOR PUNCHING MACHINE AND APPARATUS FOR PRODUCTION OF PUNCHING MACHINE
JP2005512973A5 (el)
HK1100771A1 (en) Embossed release paper for production of synthetic leather, support thereof, synthetic leather utilizing the release paper and process for producing the same
BR112012006333A2 (pt) método para produzir um polímero à base de dieno conjugado modificado, polímero à base de dieno conjugado modificado, e, composição do mesmo.
NL2000051A1 (nl) Systemen, methoden en katalysatoren voor het produceren van een ruwe-oliehoudend product.
NL2000052A1 (nl) Systemen, methoden en katalysatoren voor het produceren van een ruwe-oliehoudend product.
MX2020003424A (es) Sistema y metodo para hacer microagujas.
MY142392A (en) A process for preparing polymers of polyhydric alcohols
CL2011002633A1 (es) Procedimiento y dispositivo para fabricar papeles o paneles decorativos para pisos, entre otros, que comprende preparar una composicion de tratamiento, aplicarla sobre un sorporte y antes o despues de dicha aplicacion calentar la composicion.
NL2000053A1 (nl) Systemen, methoden en katalysatoren voor het produceren van een ruwe-oliehoudend product.
FR2964338B1 (fr) Moule pour la lithographie par nano-impression thermique, son procede de preparation, et procede de nano-impression thermique le mettant en ?uvre.
DE502006005320D1 (de) Vorrichtung zum dreiseitigen Beschnitt von Produkten
ZA200710011B (en) A method for preparing a stable immunogenic product comprising antigenic heterocomplexes of TNFα and a carrier protein
DE602005021110D1 (de) Verfahren zur herstellung von n-piperidino-1,5-diphenylpyrazol-3-carboxamid-derivaten
AR088152A1 (es) Disposicion y metodo para dispensar productos
MX2022003065A (es) Conjugados de proteína-macromolécula y métodos de uso de estos.
EP3865274A4 (en) Cushion material for hot press, and method for producing cushion material for hot press
WO2008093905A8 (en) Biocompatible aliphatic brush polymers and manufacturing methods thereof
NZ726871A (en) System and method for forming prefabricated building panels
DE502006009226D1 (de) Verfahren zur herstellung eines hohlprofils auf basis eines vernetzten, gelatine enthaltenden materials sowie implantate in form von hohlprofilen